Thomas Graddis
10Patents
4h-index
13Co-inventors
53Inventor score
Filing activity: Jul 2, 1998 → May 25, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8568706B2 | Modified human interferon-beta polypeptides | Emerging Cross-Sectional Technologies | 22 | Active |
| US6291661A | flt3-L mutants and method of use | Chemistry; Metallurgy | 18 | Expired |
| US7829659B2 | Methods of modifying polypeptides comprising non-natural amino acids | Emerging Cross-Sectional Technologies | 15 | Active |
| US7597894B2 | Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7067118B2 | Methods of using mutant flt3-ligand polypeptides to induce cellular expansion | Chemistry; Metallurgy | 3 | Expired |
| US7060279B2 | Compositions and methods for dendritic cell-based immunotherapy | Chemistry; Metallurgy | 3 | Expired |
| US8389730B2 | Compositions and methods for the treatment of disease associated with TRP-P8 expression | Physics | 2 | Active |
| US8362264B2 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | Physics | 2 | Active |
| US7659117B2 | Compositions and methods for dendritic cell-based immunotherapy | Chemistry; Metallurgy | 1 | Active |
| US9051385B2 | Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.